A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma

Thomas Eigentler, Anne Kamin, Benjamin Weide, Helmut Breuninger, Ulrich M. Caroli, Matthias Möhrle, Peter Radny, Claus Garbe

Journal of the American Academy of Dermatology · 2007 · 93 citations · 8 references

Concepts

References

8